Pharmaceuticals This is an OPML file. It can be used to export all the MedWorm RSS feeds on this topic into your personal RSS reader (usually you have to save this file to your own computer before clicking on an Import OPML command in your own feed reader to upload the file which will then import all the feeds) or it can be used by webmasters to integrate MedWorm feeds with their own website. This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader, such as GoogleReader, or to display this data on your own website or blog. Subscribe to this data using MyMedWorm.Subscribe to this data using GoogleReader.Subscribe to this data using Bloglines.Subscribe to this data using MyYahoo.

This page shows you the most recent publications within this specialty of the MedWorm directory. This is page number 22.

Bad Medicine Infiltrates MD Anderson Cancer Center
MD Anderson Cancer Center's Director of Integrative Medicine wants to offer acupuncture to all cancer patients. He is highly biased and woefully mistaken.
Source: Forbes.com Healthcare News - February 11, 2013 Category: Pharmaceuticals Authors: Steven Salzberg Source Type: news

Apax sells part of stake in Apollo for Rs 530 crore
Private equity firm Apax Partners sold 63.85 lakh shares of Apollo Hospitals Enterprise for Rs 530 crore via a bulk deal on the BSE to Oppenheimer Funds Inc.
Source: The Economic Times Healthcare and Biotech News - February 11, 2013 Category: Pharmaceuticals Source Type: news

Years of fun in the sun mean big business for local lab
Skin cancer and other skin lesions are on the rise as people live longer and more Americans are moving to sunny climes, and a Dallas dermatologist is positioning to take advantage of those demographic trends. Dr. Clay Cockerell, a dermatopathologist and dermatologist, recently purchased a 78,000-square-foot medical building in the heart of the Dallas Medical District and plans to build an independent laboratory called Cockerell Dermatopathology. It’s projected for completion this summer. He declined…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - February 11, 2013 Category: Pharmaceuticals Authors: Bill Hethcock Source Type: research

New Privacy Rules May Distract Doctors From Patient Care
My patients needed a lot of my time today. They had questions and concerns. They didn't feel well. They were short of breath, had chest pain or diarrhea or influenza or all three. The practice of medicine isn't simple.
Source: Forbes.com Healthcare News - February 11, 2013 Category: Pharmaceuticals Authors: Peter Lipson Source Type: news

UAB to soon begin search for permanent med school dean
The University of Alabama at Birmingham may spend little time without a permanent medical school dean. In a statement sent to me today, UAB announced that the search for a permanent replacement to Ray Watts, named university president Friday, will start in a few weeks. Until a permanent choice is made, Anupam Agarwal, a noted physician and academic leader at UAB, will fill the vacancy. UAB also announced last week that Agarwal was not seeking to remain in the medical school dean position permanently. Watts,…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - February 11, 2013 Category: Pharmaceuticals Authors: Yann Ranaivo Source Type: research

Earnings: Brookdale losses deepen in 4Q
Brookdale Senior Living Inc.’s losses deepened in the fourth quarter compared to the same period a year ago. The company (NYSE: BKD) posted a loss of $24.4 million, or 20 cents per share, on revenue of $699 million. Analysts, on average, had estimated a loss of seven cents per share on revenue of $699 million, according to Thomson Reuters. "We had a strong finish to the year as evidenced by the fourth quarter's occupancy increases across our segments and another good entry fee sales quarter. We…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - February 11, 2013 Category: Pharmaceuticals Authors: E.J. Boyer Source Type: research

UC Davis names interim replacement for Pomeroy
Tom Nesbitt has agreed to serve as interim vice chancellor of human health sciences and interim dean of the School Of Medicine when Dr. Claire Pomeroy steps down June 2, UC Davis Chancellor Linda Katehi announced Monday. A board certified family physician, he oversees the telemedicine program at UC Davis as associate vice chancellor for strategic technologies and alliances. Nesbitt will step down from the interim position when a new executive is selected. Pomeroy recently accepted a new job as…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - February 11, 2013 Category: Pharmaceuticals Authors: Kathy Robertson Source Type: research

Suture Health plans to add employees as contracts grow
Suture Health Inc. plans to double its staff of six within the next year as it works with companies with larger patient loads. The Birmingham-based company, which operates out of Innovation Depot, offers a service that allows physicians to log into a portal and electronically sign medical documents. Michael Blackstone, the company's founder, said Suture’s portal, known as SutureSign, services roughly 300 health care agencies, most of which average 300 to 500 patients. But he said Suture is close…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - February 11, 2013 Category: Pharmaceuticals Authors: Yann Ranaivo Source Type: research

Victory Pharma set to repay $140,000 to Illinois' Medicaid program
A specialty pharmaceutical company based in California will pay Illinois’ Medicaid program nearly $140,000 for filing false claims, Illinois Attorney General Lisa Madigan announced Monday. Victory Pharma Inc. allegedly offered kickbacks to physicians who encouraged Medicaid patients to use drugs such as Naprelan, Xodol, Fexmid and Dolgic. Illinois is not the only beneficiary of the settlement. According to Madigan’s office, Victory Pharma Inc. is set to pay $12 million to Medicaid, Medicare…
Source: bizjournals.com Health Care:Biotechnology headlines - February 11, 2013 Category: Biotechnology Authors: Samantha Liss Source Type: research

Midtown Medical changes name to Elica Health Centers
Midtown Medical Center for Children and Families, a nonprofit clinic that became Sacramento’s newest federally qualified health center last year, has changed its name to Elica Health Centers. One reason the clinic changed its name is that it currently has two sites — one on J Street in midtown and the other in West Sacramento — and is poised for more growth to meet demand when hundreds of additional patients gain access to care under federal health reform in 2014. Pronounced “Eleeka,”…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - February 11, 2013 Category: Pharmaceuticals Authors: Kathy Robertson Source Type: research

Harnessing IT to Strengthen Relationships
Connecting key information systems assures your suppliers all pull in the right direction
Source: PharmaManufacturing.com - February 11, 2013 Category: Pharmaceuticals Authors: Pharma Manufacturing Source Type: news

Outsourcing Excellence in China and India
Close collaboration effectively manages far-flung partnerships
Source: PharmaManufacturing.com - February 11, 2013 Category: Pharmaceuticals Authors: Pharma Manufacturing Source Type: news

DOJ to Treat Manufacturing Regulations as 'Top Area of Focus'
In a notable shift, the US Department of Justice (DOJ) is has announced that current good manufacturing practices (CGMPs) will be one of the agency's "top areas of focus" in the coming year, opening up new areas of uncertainty for those involved in compliance and regulatory activities for the pharmaceutical industry.
Source: PharmaManufacturing.com - February 11, 2013 Category: Pharmaceuticals Authors: Pharma Manufacturing Source Type: news

That Vitamin D You're Taking? It May Not Be What It Appears
According to research released today by Kaiser Permanente, the bottles of vitamin D on drugstore shelves may not contain nearly as much actual active vitamin as they say they do. In fact, some bottles may contain as little as 9% of the vitamin D promised on the label.
Source: Forbes.com Healthcare News - February 11, 2013 Category: Pharmaceuticals Authors: Melanie Haiken Source Type: news

World's Biggest Givers
Source: Forbes.com Healthcare News - February 11, 2013 Category: Pharmaceuticals Authors: Matthew Herper Source Type: news

In Reddit AMA, Bill Gates Discusses Vaccines, Climate Change, And Steve Jobs
You can learn a lot about the world's most generous man when he does an AMA ("ask me anything") on the popular Web site Reddit.
Source: Forbes.com Healthcare News - February 11, 2013 Category: Pharmaceuticals Authors: Matthew Herper Source Type: news

e-Therapeutics plans to raise £40m
The funds raised will include substantial further investment by Invesco Asset Management, increasing its shareholding from 45.9% to 49.9%
Source: FT.com - Drugs and Healthcare - February 11, 2013 Category: Pharmaceuticals Source Type: news

Perrigo expands UK presence
The Nasdaq-quoted group has paid more than four times the £40m annual sales of Rosemont, a Leeds-based business that sells 150 products
Source: FT.com - Drugs and Healthcare - February 11, 2013 Category: Pharmaceuticals Source Type: news

Novo Nordisk: reality check
The specialist in diabetic treatments gets hit by an FDA ruling that temporarily locks a key drug out the world’s biggest and most profitable drug market
Source: FT.com - Drugs and Healthcare - February 11, 2013 Category: Pharmaceuticals Source Type: news

Ironwood Pharmaceuticals Promotes Dr. Mark Currie to Senior Vice President, Chief Scientific Officer, and President of RandD
CAMBRIDGE, Mass.--(Healthcare Sales & Marketing Network)--Ironwood Pharmaceuticals, Inc. (IRWD) today announced the promotion of Mark Currie, Ph.D. to senior vice president, chief scientific officer (CSO), and president of research and development (R&D). ... Biopharmaceuticals, PersonnelIronwood Pharmaceuticals
Source: HSMN NewsFeed - February 11, 2013 Category: Pharmaceuticals Source Type: news

Repros Therapeutics Corporate Update
Enrollment in 6 Month Open Label Study Near Completion FDA Meeting Request Submitted Joachim F. Wernicke, Ph.D, M.D., Named Chief Medical Officer Company to Present at BIO CEO in NYC February 11, 2013 THE WOODLANDS, Texas, Feb. 11, 2013 -- (Hea... Biopharmaceuticals, FDA, PersonnelRepros Therapeutics, Androxal, Proellex
Source: HSMN NewsFeed - February 11, 2013 Category: Pharmaceuticals Source Type: news

The Sunshine Act Is Finally Final
This article was created due to the hard work of Scott Liebman and Christine Bradshaw of Porzio, Bromberg and Newman. Both can be reached for further comment through the firms site. You can also follow me or Scott on twitter: @ScottLiebmanPLS or @nic_fisher.
Source: Forbes.com Healthcare News - February 11, 2013 Category: Pharmaceuticals Authors: Nicole Fender Fisher Source Type: news

Social Media Watchers Stunned: Pope Benedict XVI Resignation Forsakes Twitter
Pope Benedict XVI has become the first pontiff to resign since the 15th century. The leader of the world's more than 1 billion Roman Catholic worshippers cited health reasons behind his wish to step down, effective February 28.
Source: Forbes.com Healthcare News - February 11, 2013 Category: Pharmaceuticals Authors: David Kroll Source Type: news

Stretta(R) Therapy for GERD Receives Strongest Recommendation in SAGES New Clinical Guideline
Quality of Evidence: (++++) Grade Recommendation: Strong (Highest) GREENWICH, Conn., Feb. 11, 2013 -- (Healthcare Sales & Marketing Network) -- Mederi Therapeutics Inc. today announced that the Society of American Gastrointestinal and Endoscopic Sur... Devices, GastroenterologyMederi Therapeutics, Stretta therapy, GERD , radiofrequency
Source: HSMN NewsFeed - February 11, 2013 Category: Pharmaceuticals Source Type: news

Alliqua Demonstrates Wound Healing Benefit of SilverSeal(R) Dressing on Foot and Ankle Post-Surgical Wounds
Reduction in Scarring and Incidence of Infections Observed NEW YORK, Feb. 11, 2013 -- (Healthcare Sales & Marketing Network) -- Alliqua, Inc. (ALQA) ("Alliqua" or the "Company") today announced interim results from a post-marketing ... Devices, Wound CareAlliqua, SilverSeal, wound dressing
Source: HSMN NewsFeed - February 11, 2013 Category: Pharmaceuticals Source Type: news

Bayer Submits New Drug Application for Riociguat for the Treatment of Pulmonary Arterial Hypertension and Persistent/Recurrent Chronic Thromboembolic Pulmonary Hypertension
WAYNE, N.J., Feb. 11, 2013 -- (Healthcare Sales & Marketing Network) -- Bayer HealthCare today announced that the company has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) seeking approval for riociguat, an investig... BiopharmaceuticalsBayer HealthCare, riociguat, pulmonary arterial hypertension, CTEPH
Source: HSMN NewsFeed - February 11, 2013 Category: Pharmaceuticals Source Type: news

Cardiorentis initiates first-ever acute heart failure Phase III clinical trial designed to assess early treatment on cardiovascular mortality and symptoms
ZUG, Switzerland, February 11, 2013 -- (Healthcare Sales & Marketing Network) --Cardiorentis has initiated the first-ever acute heart failure (AHF) Phase III trial to be specifically designed to assess the effect of early treatment on cardiovascular morta... Biopharmaceuticals, CardiologyCardiorentis, TRUE-AHF, ularitide, heart failure
Source: HSMN NewsFeed - February 11, 2013 Category: Pharmaceuticals Source Type: news

TranS1 Inc. Announces Coverage Milestone
WILMINGTON, N.C., Feb. 11, 2013 -- (Healthcare Sales & Marketing Network) -- TranS1 Inc. (TSON), a medical device company focused on designing, developing and marketing products to treat degenerative conditions of the spine affecting the lumbar region, ann... Devices, Neurosurgery, Orthopaedic, ReimbursementTranS1, pre-sacral interbody fusion, interbody fusion, AxiaLIF, spine surgery
Source: HSMN NewsFeed - February 11, 2013 Category: Pharmaceuticals Source Type: news

Meat, Fat, Insulin And Other Health News To Start Your Morning
A bunch of health links and thoughts to start your week:
Source: Forbes.com Healthcare News - February 11, 2013 Category: Pharmaceuticals Authors: Matthew Herper Source Type: news

Public can see pharma payments to doctors starting in 2014
Revisions in the final transparency rule will give physicians more time to resolve payment amounts and won’t require disclosure of indirect pay from accredited education programs.
Source: American Medical News - GOVERNMENT - February 11, 2013 Category: American Health Source Type: news

Regulatory Concerns Aren't The Only Roadblock In Developing Patient Interaction Strategies
The biggest challenge to pharmaceutical companies implementing patient-centered programs is a failure to communicate priorities effectively between patient adherence teams and both marketing and legal teams, according to a study by Cutting Edge Information.
Source: Pharmaceutical Online News - February 11, 2013 Category: Pharmaceuticals Source Type: news

NETZSCH Announces Appointment of New Pharmaceutical Business Development Manager
Today, NETZSCH Premier Technologies announced that Rajesh Mukherjee has joined the company as the Business Development Manager for Pharmaceutical Applications, located in Exton, PA.
Source: Pharmaceutical Technology - February 11, 2013 Category: Pharmaceuticals Source Type: news

02.12.12 -- Pharmaceutical Track & Trace: A Year In Review
02/12/12 Pharmaceutical Online Newsletter
Source: Pharmaceutical Online News - February 11, 2013 Category: Pharmaceuticals Source Type: news

New 3-D Control Opens Wealth Of Options For Drug Makers
A team of scientists anchored at Yale University has demonstrated a new, highly versatile approach for quickly assembling drug-like compounds, establishing a broad new route to drug discovery and medical treatment. They report their results in the journal Science. Drug molecules interact with their targets, such as proteins or enzymes, by attaching to them in a way that neutralizes the target's undesirable effects in the body. This is sometimes called the "lock-and-key" method...
Source: Health News from Medical News Today - February 11, 2013 Category: Consumer Health News Tags: Pharma Industry / Biotech Industry Source Type: news

Patheon To Host A Seminar On "Getting Your Drug Through Phase I Early Development Effectively"
Patheon will host a complimentary Seminar on “Getting Your Drug through Phase I Early Development Effectively” at the Milton Park, UK Facilit. The seminar will be held on Tuesday, February 19th at 11:30 – 6 p.m. Central European Time at Patheon’s Milton Park facility in Oxfordshire, UK.
Source: Pharmaceutical Online News - February 11, 2013 Category: Pharmaceuticals Source Type: news

Patheon Announces First Phase Of The UK Facility To Expand Early Development Capabilities In Europe
With the first phase of additional investment to Patheon’s Milton Park facility, the company will be able to expand upon the early development capabilities currently being offered, including the introduction of the SoluPath program.
Source: Pharmaceutical Online News - February 11, 2013 Category: Pharmaceuticals Source Type: news

Laminar Flow Hoods, Biosafety Cabinets And Containment Of Aerosols And Bioaerosols
The following discussion describes Laminar Flow Hoods, Biological Safety Cabinets (BSCs), their design, use, designations, similarities and differences. It also explains the use and application of Flow Sciences Laminar Flow Hood (Ventilated Weigh Enclosures and Ventilated Work Stations) and their applicability for use with bioaerosols. By George S. Petroka, CIH, CSP, RBP, Director BioPharma/EHS Service
Source: Pharmaceutical Online News - February 11, 2013 Category: Pharmaceuticals Source Type: news

Lantheus Medical Imaging Announces FDA Approval Of Jubilant HollisterStier As A New Manufacturing Site For DEFINITY
Lantheus Medical Imaging, Inc., a global leader in developing, manufacturing and distributing innovative diagnostic imaging agents, recently announced that the U.S.
Source: Pharmaceutical Online News - February 11, 2013 Category: Pharmaceuticals Source Type: news

CDER Program Allows Regulators to Gain Insight into Pharma Industry
US regulators announced this week that they intend to continue a program they say allows companies to invite pharmaceutical regulatory officials into their facilities to go on site tours to learn more about the pharmaceutical industry and the way it produces its products.The plan, known as the Regulatory Project Management Site Tours and Regulatory Interaction Program, or the Site Tours Program, has been in effect in various forms since 1999, when it was created by the Center for Drug Evaluation Research's (CDER) Training and Certification Subcommittee.
Source: PharmaManufacturing.com - February 11, 2013 Category: Pharmaceuticals Authors: Pharma Manufacturing Source Type: news

Predevelopment Tasks for Drug Making
Explore the impact of predevelopment activities on drug product safety, stability, quality, identity, purity and potency.
Source: PharmaManufacturing.com - February 11, 2013 Category: Pharmaceuticals Authors: Pharma Manufacturing Source Type: news

DOJ Announces Manufacturing Regs as 'Top Area of Focus'
The U.S. Department of Justice (DOJ) has announced that current good manufacturing practices (CGMPs) will be one of the agency's "top areas of focus" in the coming year, opening up new areas of uncertainty for those involved in compliance and regulatory activities for the pharmaceutical industry.
Source: PharmaManufacturing.com - February 11, 2013 Category: Pharmaceuticals Authors: Pharma Manufacturing Source Type: news

Medicaid Sparks New Fight Over Health Care
Employers in several states are bracing for higher health-care costs as some governors, worried about the impact on state budgets from the federal overhaul, resist a planned Medicaid expansion.
Source: WSJ.com: Health - February 11, 2013 Category: Pharmaceuticals Tags: PAID Source Type: news

Bayer’s Riociguat for Patients with Chronic Thromboembolic Pulmonary Hypertension and Pulmonary Arterial Hypertension Submitted For Regulatory Approval in the U.S. and EU (for specialized target groups only)
Riociguat is the first drug that has consistently demonstrated efficacy in two life-threatening PH indications – chronic thromboembolic pulmonary hypertension (CTEPH) and pulmonary arterial hypertension (PAH)
Source: Bayer Company News - February 11, 2013 Category: Pharmaceuticals Source Type: news

Seeking Cardiovascular Safety Data, FDA Blocks Approval Of Novo Nordisk's Long-Acting Insulin
The FDA informed Novo Nordisk on Friday that it would not approve the company's highly anticipated long-acting insulin degludec products (Tresiba and Ryzodeg) until it receives data from a cardiovascular outcomes trial. Approval of the drugs had been widely anticipated for this year, following a positive recommendation from an FDA advisory committee last fall. But the committee also unanimously recommended that the company be required to perform a cardiovascular outcomes trial.
Source: Forbes.com Healthcare News - February 11, 2013 Category: Pharmaceuticals Authors: Larry Husten Source Type: news

Bad Pharma
Source: JRSM - February 11, 2013 Category: UK Health Authors: Edwards, N. Tags: Media Source Type: research

THERAPY PAIN (Menthol Methyl Salicylate Capsaicin) Gel [Cal Pharma]
Updated Date: Feb 11, 2013 EST
Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST) - February 11, 2013 Category: Drugs & Pharmacology Source Type: news

ATENOLOLtablet [Med-Health Pharma, LLC]
Updated Date: Feb 11, 2013 EST
Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST) - February 11, 2013 Category: Drugs & Pharmacology Source Type: news

Cipla puts Medpro buyout on hold over valuation
Cipla decides to put on hold its $220-million acquisition plan of the third-largest South African drugmaker Cipla Medpro due to valuation issues.
Source: The Economic Times Healthcare and Biotech News - February 10, 2013 Category: Pharmaceuticals Source Type: news

In Medicaid, a New Health-Care Fight
Employers in several states are bracing for higher health-care costs as some governors, worried about the impact on state budgets from the federal overhaul, resist a planned Medicaid expansion.
Source: WSJ.com: Health - February 10, 2013 Category: Pharmaceuticals Tags: PAID Source Type: news